ArticleActa otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale2025
Italian multicentre study to validate the Swallowing Outcome After Laryngectomy (SOAL) questionnaire.
Article in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To report the data obtained by translating the Swallowing Outcomes After Laryngectomy (SOAL) questionnaire in Italian to validate it and offer a valid tool for Italian-speaking patients and clinicians. Methods: A multicentre case-control study was performed between January 1st 2024 and October 1st 2024. In all, 494 patients consecutively treated for laryngeal squamous cell carcinoma were included in the study (group 1). Healthy controls and patients who underwent radiotherapy (group 2) or chemotherapy (group 3) of the head and neck district were the two control groups. Results: Statistically significant differences were observed comparing SOAL scores among the three groups (ANOVA: p < 0.0001); significant differences were observed between group 1 (mean 0.89 +/- 1.31; 95% CI: 0-3) and group 2 (mean 6.78 +/- 4.59; 95% CI: 1-24) (Bonferroni-Holmes [BH] p < 0.01), and group 1 and group 3 (mean 11 +/- 7.47; 95% CI: 0-38) (BH: p 0 < 0.01). Statistically significant differences in the SOAL scores were also identified between group 2 and 3 (BH: p < 0.01). Conclusions: The SOAL questionnaire may be a useful tool to correctly understand patients' concerns for swallowing to promptly and rapidly manage them and improve patient's quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.